Email ID
Password
Scrip   
Sanofi-Aventis to spend up to $1.1 billion in eyecare and cancer deals
01 October 2009
Simon Varcoe

Sanofi-Aventis is to acquire the French R&D company Fovea Pharmaceuticals for up to €370 million ($541 million) in order to expand its ophthalmology business. It has also signed a licensing deal with Merrimack Pharmaceuticals that could be worth up to $530 million to the private...



Please Login to read the full article.
JOB OF THE WEEK Promote your vacancy here
© 2010 Informa plc. All rights reserved.
This site is owned and operated by Informa plc ("Informa") whose registered office is Mortimer House, 37-41 Mortimer Street, London, W1T 3JH. Registered in England and Wales. Number 3099067. UK VAT Group: GB 365 4626 36